Is the InvoCare Limited share price a buy for its long-term growth and 5% dividend?

The InvoCare Limited (ASX:IVC) share price is looking attractive to me.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The InvoCare Limited (ASX: IVC) share price hit a 52-week low today, so it's worth asking if the leading funeral operator in Australia is a buy today.

Here are my bull and bear reasons:

Bull case

InvoCare operates in a long-term growth industry. As morbid as it sounds, the number of people dying each year in Australia is increasing due to Australia's ageing (and growing) population.

According to numbers produced by the Australian Bureau of Statistics 'death volumes' are expected to grow by 1.4% per annum between 2016 to 2025 and then increase by 2.2% per annum from 2025 to 2050.

InvoCare has different brands, like White Lady Funerals and Value Cremations, to appeal to customers with different budgets. It should be able to capture a lot of the future industry growth.

I also like that the company has paid out a growing dividend each year since 2006. It currently has a grossed-up dividend yield of 5.23%.

Bear case

One of the main reasons why the share price has fallen from $17.98 to today's $12.57 is that the UK equivalent of InvoCare has recently had to reduce prices due to competitors. At the moment InvoCare's only real competitor is Propel Funeral Partners Ltd (ASX: PFP) but there could be others in the future.

InvoCare has also said that this year's operating profit won't be much different to last year's because it is heavily investing to redevelop its sites to cater for the changing demands. There are renovating costs to this and closing down the site for a while loses revenue.

The third reason to be bearish on InvoCare is rising interest rates in the US. Defensive stocks look a lot less attractive when US bonds offer a higher yield than they used to.

Foolish takeaway

I think InvoCare is worth considering for long-term investors. It is currently trading at 22x FY18's estimated earnings, which I think is a reasonable price to pay for such a defensive business.

Motley Fool contributor Tristan Harrison owns shares of InvoCare Limited and Propel Funeral Partners Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »